Insights into antifolate activity of phytochemicals against Pseudomonas aeruginosa

Journal of Drug Targeting

Volumn 19, Issue 3, 2011, Pages 179-188

  Jayaraman, Premkumar ^a,b   Sakharkar, Kishore R ^a,c   Sing, Lim Chu ^a,b   Chow, Vincent T K ^d   Sakharkar, Meena K ^a,b  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^b NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^c OmicsVista   (Singapore)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

drug resistance; molecular modeling; phytochemicals; Synergy

Indexed keywords

DIHYDROFOLATE REDUCTASE; FOLIC ACID; GALLIC ACID; MYRICETIN; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; PROTOCATECHUIC ACID; QUERCETIN; SULFAMETHOXAZOLE; TRIMETHOPRIM;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME ACTIVE SITE; ENZYME BINDING; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR DOCKING; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ANTI-INFECTIVE AGENTS; BIOLOGICAL PRODUCTS; DRUG INTERACTIONS; DRUG SCREENING ASSAYS, ANTITUMOR; DRUG SYNERGISM; FOLIC ACID ANTAGONISTS; MICROBIAL SENSITIVITY TESTS; MOLECULAR CONFORMATION; PHYTOTHERAPY; PSEUDOMONAS AERUGINOSA; TETRAHYDROFOLATE DEHYDROGENASE;

EID: 79952678774     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/10611861003801867     Document Type: Article

References (33)

1. CLSI guidelines. (1992). Methods for Determining Bactericidal Activity of Antimicrobial Agents: Tentative Guideline M26-T. Methods for Determining Bactericidal Activity of Antimicrobial Agents.
2. Achari A, Somers DO, Champness JN, Bryant PK, Rosemond J, Stammers DK. (1997). Crystal structure of the anti-bacterial sulfonamide drug target dihydropteroate synthase. Nat Struct Biol, 4, 490-497. (Pubitemid 27263603)
3. Amyes SG, Walsh FM, Bradley JS. (2007). Best in class: a good principle for antibiotic usage to limit resistance development? J Antimicrob Chemother, 59, 825-826. (Pubitemid 47073350)
4. Arnold K, Bordoli L, Kopp J, Schwede T. (2006). Te SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics, 22, 195-201. (Pubitemid 43205406)
5. Bermingham A, Derrick JP. (2002). Te folic acid biosynthesis pathway in bacteria: evaluation of potential for antibacterial drug discovery. Bioessays, 24, 637-648. (Pubitemid 34780351)
6. Brown PD, Izundu A. (2004). Antibiotic resistance in clinical isolates of Pseudomonas aeruginosa in Jamaica. Rev Panam Salud Publica, 16, 125-130. (Pubitemid 39223278)
7. Coutinho HDM, Costa JGM, Lima EO, Falcão-Silva VS, Siqueira Jr JP. (2009). Herbal therapy associated with antibiotic therapy: Potentiation of the antibiotic activity against methicillin-Resistant Staphylococcus aureus by Turnera ulmifolia L. BMC Complement Altern Med, 9, 13.
8. Coutinho HD, Costa JG, Lima EO, Falcão-Silva VS, Siqueira-Júnior JP. (2008). Enhancement of the antibiotic activity against a multiresistant Escherichia coli by Mentha arvensis L. and chlorpromazine. Chemotherapy, 54, 328-330.
9. El Gharras H. (2009). Polyphenols: Food sources, properties and applications-A review. Int J Food Sci and Tech, 44, 2512-2518.
10. Eswar N, Eramian D, Webb B, Shen MY, Sali A. (2008). Protein structure modeling with MODELLER. Methods Mol Biol, 426, 145-159.
11. Garo E, Eldridge GR, Goering MG, DeLancey Pulcini E, Hamilton MA, Costerton JW, James GA. (2007). Asiatic acid and corosolic acid enhance the susceptibility of Pseudomonas aeruginosa bioflms to tobramycin. Antimicrob Agents Chemother, 51, 1813-1817. (Pubitemid 46744162)
12. Hancock REW. (1997). Te bacterial outer membrane as a drug barrier. Trends Microbiol, 5, 37-42. (Pubitemid 27077171)
13. Hawser S, Lociuro S, Islam K. (2006). Dihydrofolate reductase inhibitors as antibacterial agents. Biochem Pharmacol, 71, 941-948.
14. Hemaiswarya S, Kruthiventi AK, Doble M. (2008). Synergism between natural products and antibiotics against infectious diseases. Phytomedicine, 15, 639-652.
15. Hill SF, Haldane DJ, Ngui-Yen JH, Smith JA. (1985). In vitro susceptibility of Pseudomonas species to carbenicillin and trimethoprim- sulfamethoxazole. J Clin Microbiol, 22, 465-466. (Pubitemid 15018594)
16. Huovinen P. (2001). Resistance to trimethoprim-sulfamethoxazole. Clin Infect Dis, 32, 1608-1614. (Pubitemid 32458729)
17. Kipnis E, Sawa T, Wiener-Kronish J. (2006). Targeting mechanisms of Pseudomonas aeruginosa pathogenesis. Med Mal Infect, 36, 78-91. (Pubitemid 43294628)
18. Lai S, Tremblay J, Déziel E. (2009). Swarming motility: a multicellular behaviour conferring antimicrobial resistance. Environ Microbiol, 11, 126-136.
19. Lister PD, Wolter DJ, Hanson ND. (2009). Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin Microbiol Rev, 22, 582-610.
20. Litzow JM, Gill CJ, Mantaring JB, Fox MP, MacLeod WB, Mendoza M, Mendoza S, Scobie R, Huskins CW, Goldman DA, Hamer DH. (2009). High frequency of multidrug-resistant gram-negative rods in 2 neonatal intensive care units in the Philippines. Infect Control Hosp Epidemiol, 30, 543-549.
21. Masters PA, O'Bryan TA, Zurlo J, Miller DQ, Joshi N. (2003). Trimethoprim-sulfamethoxazole revisit. ed. Arch Intern Med, 163, 402-410.
22. McGowan JE Jr. (2006). Resistance in nonfermenting gram-negative bacteria: multidrug resistance to the maximum. Am J Infect Control, 34, S29-37; discussion S64. (Pubitemid 43928175)
23. Navarro-Martínez MD, Navarro-Perán E, Cabezas-Herrera J, Ruiz-Gómez J, García-Cánovas F, Rodríguez- López JN. (2005). Antifolate activity of epigallocatechin gallate against Stenotrophomonas maltophilia. Antimicrob Agents Chemother, 49, 2914-2920. (Pubitemid 40917610)
24. Nicotra MB, Rivera M, Dale AM, Shepherd R, Carter R. (1995). Clinical, pathophysiologic, and microbiologic characterization of bronchiectasis in an aging cohort. Chest, 108, 955-961.
25. Obritsch MD, Fish DN, MacLaren R, Jung R. (2005). Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options. Pharmacotherapy, 25, 1353-1364. (Pubitemid 41407633)
26. Rubin J, Yu VL. (1988). Malignant external otitis: insights into pathogenesis, clinical manifestations, diagnosis, and therapy. Am J Med, 85, 391-398.
27. Spina M, Cuccioloni M, Mozzicafreddo M, Montecchia F, Pucciarelli S, Eleuteri AM, Fioretti E, Angeletti M. (2008). Mechanism of inhibition of wt-dihydrofolate reductase from E. coli by tea epigallocatechin-gallate. Proteins, 72, 240-251. (Pubitemid 351809162)
28. Stern GA. (1990). Pseudomonas keratitis and contact lens wear: the lens/eye is at fault. Cornea, 9 Suppl 1, S36-8; discussion S39. (Pubitemid 20176218)
29. Strateva T, Yordanov D. (2009). Pseudomonas aeruginosa-a phenomenon of bacterial resistance. J Med Microbiol, 58, 1133-1148.
30. Tomsen R, Christensen MH. (2006). MolDock: a new technique for high-accuracy molecular docking. J Med Chem, 49, 3315-3321. (Pubitemid 43830529)
31. Ulrich-Merzenich G, Panek D, Zeitler H, Wagner H, Vetter H. (2009). New perspectives for synergy research with the "omic"-technologies. Phytomedicine, 16, 495-508.
32. Wagner H, Ulrich-Merzenich G. (2009). Synergy research: approaching a new generation of phytopharmaceuticals. Phytomedicine, 16, 97-110.
33. Wang MC, Liu CY, Shiao AS, Wang T. (2005). Ear problems in swimmers. J Chin Med Assoc, 68, 347-352. (Pubitemid 41200586)